Because of the extreme scarcity of HSPCs in FA patients, we tested the efficiency of gene editing in Lineage depleted (Lin-) cells from one patient and CD34+ enriched cells from three different FA patients, all carrying the FANCA c.295 C > T mutation as in FA-55 LCLs (Fig. 6). This evidence concerns the gene CD34 and Friedreich ataxia.